Skip to main content


Page 4 of 80

  1. Anemia has been reported as a risk factor for chronic kidney disease (CKD) progression. However, there are still few studies examining the relationship between specific hemoglobin (Hb) levels and renal prognos...

    Authors: Wushan Pan, Yong Han, Haofei Hu and Yongcheng He
    Citation: BMC Nephrology 2022 23:295
  2. Acute kidney injury is a common complication in solid organ transplants, notably liver transplantation. The MELD is a score validated to predict mortality of cirrhotic patients, which is also used for organ al...

    Authors: Paulo Ricardo Gessolo Lins, Roberto Camargo Narciso, Leonardo Rolim Ferraz, Virgilio Gonçalves Pereira, Ben-Hur Ferraz-Neto, Marcio Dias De Almeida, Bento Fortunato Cardoso Dos Santos, Oscar Fernando Pavão Dos Santos, Júlio Cesar Martins Monte, Marcelino Souza Durão Júnior and Marcelo Costa Batista
    Citation: BMC Nephrology 2022 23:294
  3. The association between cardiac complications, such as heart failure (HF), and chronic kidney disease (CKD) is well known. In this study, we examined the effectiveness and safety of treatment with neprilysin i...

    Authors: María Dolores Martínez-Esteban, Teresa Vázquez-Sánchez, Rafael Pozo-Álvarez, Alicia Moreno-Ortiz, Juana Alonso-Titos, Guillermo Martín-Reyes, Pedro Ruiz-Esteban, Daniel Gaitán-Román and Domingo Hernández
    Citation: BMC Nephrology 2022 23:293
  4. Telehealth could potentially increase independency and autonomy of patients treated with peritoneal dialysis (PD). Moreover, it might improve clinical and economic outcomes. The demand for telehealth modalitie...

    Authors: Geertje K. M. Biebuyck, Aegida Neradova, Carola W. H. de Fijter and Lily Jakulj
    Citation: BMC Nephrology 2022 23:292
  5. Hyperphosphatemia occurs frequently in end-stage renal disease patients on hemodialysis and is associated with increased mortality. Hyperphosphatemia contributes to vascular calcification in these patients, bu...

    Authors: Jinwoo Jung, Haekyung Jeon-Slaughter, Hang Nguyen, Jiten Patel, Kamalanathan K. Sambandam, Shani Shastri and Peter Noel Van Buren
    Citation: BMC Nephrology 2022 23:291
  6. Tuberculosis (TBC) in solid organ transplant recipients represents a severe complication. The incidence among transplant recipients is higher than in the general population, and the diagnosis and treatment rem...

    Authors: Kamila Bednarova, Janka Slatinska, Ondrej Fabian, Pavel Wohl, Emilia Kopecka and Ondrej Viklicky
    Citation: BMC Nephrology 2022 23:290
  7. Restriction of sodium intake is routinely recommended for patients with chronic kidney disease (CKD). Whether or not sodium intake is associated with the progression of CKD and mortality remains uncertain. We ...

    Authors: Cecília Malheiro Cury, Vanessa Burgugi Banin, Pamela Falbo dos Reis, Jacqueline Costa Teixeira Caramori, Pasqual Barretti, Luís Gustavo Modelli de Andrade and Luis Cuadrado Martin
    Citation: BMC Nephrology 2022 23:289
  8. Glycated albumin (GA) is known to reflect the current inflammatory burden in non-diabetes mellitus (DM) patients. In this study, we investigated whether GA at diagnosis could reflect the cross-sectional activi...

    Authors: Pil Gyu Park, Jung Yoon Pyo, Sung Soo Ahn, Jason Jungsik Song, Yong-Beom Park and Sang-Won Lee
    Citation: BMC Nephrology 2022 23:288
  9. The electronic health record (EHR), utilized to apply statistical methodology, assists provider decision-making, including during the care of chronic kidney disease (CKD) patients. When estimated glomerular fi...

    Authors: Reyhaneh Zafarnejad, Steven Dumbauld, Diane Dumbauld, Mohammad Adibuzzaman, Paul Griffin and Edwin Rutsky
    Citation: BMC Nephrology 2022 23:287
  10. In chronic kidney disease (CKD), like in IgA nephropathy (IgAN), cardiovascular (CV) mortality and morbidity are many times higher than in the general population, and left ventricular hypertrophy (LVH) is an i...

    Authors: Balázs Sági, István Késői, Tibor Vas, Botond Csiky, Judit Nagy and Tibor József Kovács
    Citation: BMC Nephrology 2022 23:285
  11. Kidney transplantation is an effective treatment for end-stage renal disease (ESRD). Delayed graft function (DGF) is a common complication after kidney transplantation and exerts substantial effects on graft f...

    Authors: Shitao Zhao, Yuan Liu, Chen Zhou, Zide Chen, Zeyu Cai, JiaLiang Han, Jiansheng Xiao and Qi Xiao
    Citation: BMC Nephrology 2022 23:284
  12. Kidney transplantation in older people has increased, however older transplant recipients experience mixed outcomes that invariably impacts on their quality of life. The increased vulnerability of older end st...

    Authors: Amarpreet K. Thind, Annabel Rule, Dawn Goodall, Shuli Levy, Sarah Brice, Frank J. M. F. Dor, Nicola Evans, David Ospalla, Nicola Thomas, David Wellsted, Lina Johansson, Michelle Willicombe and Edwina A. Brown
    Citation: BMC Nephrology 2022 23:283
  13. Community engagement is essential for effective research when addressing issues important to both the community and researchers. Despite its effectiveness, there is limited published evidence concerning the ev...

    Authors: Angie Aguilar-González, Randall Lou-Meda, André Chocó-Cedillos and Louise Moist
    Citation: BMC Nephrology 2022 23:282
  14. Hyperkalaemia is common in patients with chronic kidney disease (CKD) and is associated with a range of adverse outcomes. Historically, options for management of chronic hyperkalaemia in the outpatient setting...

    Authors: Kun Kim, Josefine Fagerström, Gengshi Chen, Zoya Lagunova, Hans Furuland and Phil McEwan
    Citation: BMC Nephrology 2022 23:281
  15. Many individuals living with chronic kidney disease (CKD) have comorbid Type 2 diabetes (T2D). We sought to explore if efficacious interventions that improve glycemic control may also have potential to reduce ...

    Authors: McKenzie K. Roddy, Lindsay S. Mayberry, Devika Nair and Kerri L. Cavanaugh
    Citation: BMC Nephrology 2022 23:280
  16. The first case of Taralomyces flavus infection in human and peritoneal dialysis (PD) patient after exposure to biocontrol agent fumes is reported here.

    Authors: Phanit Sookto, Talerngsak Kanjanabuch, Tamonwan Chamroensakchai, Nisa Thongbor and Somchai Eiam-Ong
    Citation: BMC Nephrology 2022 23:279
  17. Monoclonal gammopathy of renal significance (MGRS) encompasses a heterogeneous group of kidney diseases in which a monoclonal immunoglobulin secreted by a clone of B cells or plasma cells causes kidney damage ...

    Authors: Gabriel Brayan Gutiérrez-Peredo, José César Batista Oliveira Filho, Iris Montaño-Castellón, Andrea Jimena Gutiérrez-Peredo, Edvan de Queiroz Crusoé and Dimitri Gusmao-Flores
    Citation: BMC Nephrology 2022 23:278
  18. The number of chronic kidney disease (CKD) patients continues to increase worldwide. CKD patients need to take phosphate binders to manage serum phosphorus concentrations. Currently, several types of phosphate...

    Authors: Akiko Hashimoto, Jiaqi Gao, Yuki Kanome, Yukihiro Ogawa, Masaharu Nakatsu, Masahiro Kohno and Koji Fukui
    Citation: BMC Nephrology 2022 23:277
  19. Patients with end-stage kidney disease (ESKD) may choose to undergo dialysis in-center or at home, but uptake of home dialysis in the US has been minimal despite its benefits over in-center dialysis. Factors t...

    Authors: Miriam Vélez-Bermúdez, Jenna L. Adamowicz, Natoshia M. Askelson, Susan K. Lutgendorf, Mony Fraer and Alan J. Christensen
    Citation: BMC Nephrology 2022 23:276
  20. Over the last three decades, the mesoamerican region has seen an increase in the frequency of patients diagnosed with Chronic Kidney Disease of nontraditional causes (CKDnt) also known as Meso-American Nephrop...

    Authors: Karen Courville, Norman Bustamante, Bárbara Hurtado, Maydelin Pecchio, Clarissa Rodríguez, Virginia Núñez-Samudio and Iván Landires
    Citation: BMC Nephrology 2022 23:275
  21. Haemostatic derangements are thought to be due to an imbalance between hepatic synthesis of pro-coagulants and urinary losses of anticoagulants.

    Authors: Chioma L. Odimegwu, Anthony N. Ikefuna, Henrietta U. Okafor, Theresa Nwagha, Agozie Ubesie and Josephat M. Chinawa
    Citation: BMC Nephrology 2022 23:274
  22. Chronic kidney disease (CKD) is responsible for large personal health and societal burdens. Screening populations at higher risk for CKD is effective to initiate earlier treatment and decelerate disease progre...

    Authors: Susanne Stolpe, Bernd Kowall, Denise Zwanziger, Mirjam Frank, Karl-Heinz Jöckel, Raimund Erbel and Andreas Stang
    Citation: BMC Nephrology 2022 23:272
  23. We report a case of a patient who suffered thrombosis of a radial artery-cephalic vein fistula accompanied by aneurysm and a single outflow path of the elbow perforating vein. We performed open surgery combine...

    Authors: Ziqiang Wang, Yifen Hong, Zefeng Wei, Juan Chen, Li Li and Yongjun Zhu
    Citation: BMC Nephrology 2022 23:271
  24. Currently, there is a lack of clinical indicators that can accurately distinguish diabetic kidney disease (DKD) from non-diabetic kidney disease (NDKD) in type 2 diabetes. The purpose of this study was to inve...

    Authors: Jing Wei, Bo Wang, Feng-jie Shen, Ting-ting Zhang, Zan Duan and Dong-mei Zhou
    Citation: BMC Nephrology 2022 23:270
  25. Many people living with chronic kidney disease (CKD) are iron deficient, even though they may not be anaemic. The Iron and Muscle study aims to evaluate whether iron supplementation reduces symptoms of fatigue...

    Authors: Sharlene A. Greenwood, Nicholas Beckley-Hoelscher, Elham Asgari, Salma Ayis, Luke A. Baker, Debasish Banerjee, Sunil Bhandari, Kate Bramham, Joseph Chilcot, James Burton, Philip A. Kalra, Courtney J. Lightfoot, Kieran McCafferty, Thomas H. Mercer, Darlington O. Okonko, Benjamin Oliveira…
    Citation: BMC Nephrology 2022 23:268
  26. Gitelman syndrome (GS) is a rare autosomal recessive inherited salt-losing tubulopathy (SLT). Here, we report, for the first time, a case of GS overlapping nephrotic syndrome (NS) related to PLA2R-associated m...

    Authors: Xiafei Guo, Shanshen Yu, Jia Sun and Lijun Mou
    Citation: BMC Nephrology 2022 23:267
  27. Good knowledge and early identification of chronic kidney disease (CKD) can help in preventing disease progression in its early stages and reducing undesired outcomes. The aim of the current study was to asses...

    Authors: Samar Younes, Nisreen Mourad, Jihan Safwan, Mariam Dabbous, Mohamad Rahal, Marah Al Nabulsi and Fouad Sakr
    Citation: BMC Nephrology 2022 23:266
  28. Glomerular endotheliosis is the pathognomonic glomerular lesion in pre-eclampsia that has also been described in those taking tyrosine kinase inhibitors for cancer treatment. Ibrutinib is a Bruton’s tyrosine k...

    Authors: Amy Li, Sophia L. Ambruso, Ozgur Akin Oto, Marc Barry and Charles L. Edelstein
    Citation: BMC Nephrology 2022 23:264
  29. Residual kidney function (RKF) may provide many benefits to patients on permanent renal replacement therapy that are reflected in better control of biochemical parameters. In hemodialysis patients, quality of ...

    Authors: Asmaa Elgendy, Adel I. Abdelsalam, Mostafa Mansour and Mohammed K. Nassar
    Citation: BMC Nephrology 2022 23:263
  30. TAFRO syndrome is an acute or subacute systemic inflammatory disease with no apparent cause, presenting with fever, generalized edema, thrombocytopenia, renal damage, anemia, and organ enlargement. Interleukin...

    Authors: Takahide Iwasaki, Kosuke Mizusaki, Miwa Masumoto, Yuko Minagawa, Kouta Azuma, Tetsuya Furukawa, Makoto Yoshida and Takahiro Kuragano
    Citation: BMC Nephrology 2022 23:262
  31. Frailty is highly prevalent in people receiving haemodialysis (HD) and is associated with poor outcomes. Understanding the lived experiences of this group is essential to inform holistic care delivery.

    Authors: Hannah M. L. Young, Nicki Ruddock, Mary Harrison, Samantha Goodliffe, Courtney J. Lightfoot, Juliette Mayes, Andrew C. Nixon, Sharlene A. Greenwood, Simon Conroy, Sally J. Singh, James O. Burton, Alice C. Smith and Helen Eborall
    Citation: BMC Nephrology 2022 23:260
  32. Gut microbiota dysbiosis in patients with chronic kidney disease on haemodialysis (CKD-HD) creates an increase in proteolytic bacteria activity, leading to an increase in the production of uraemic toxins, such...

    Authors: Aida Lydia, Tities Anggraeni Indra, Aulia Rizka and Murdani Abdullah
    Citation: BMC Nephrology 2022 23:259
  33. Given the complexity and variety in treatment options for advanced chronic kidney disease (CKD), shared decision-making (SDM) can be a challenge. SDM is needed for making decisions that best suit patients’ nee...

    Authors: Sandra van Dulmen, Ruud Roodbeen, Lotte Schulze, Karen Prantl, Maarten Rookmaaker, Brigit van Jaarsveld, Janneke Noordman and Alferso Abrahams
    Citation: BMC Nephrology 2022 23:258
  34. To evaluate the presence of LGA and the relationship with the 10-year risk of a cardiovascular event in hypertensive and diabetic patients in Primary Health Care.

    Authors: Ramon Augusto Ferreira de Souza, Eunice Ferreira da Silva, Deíse Moura de Oliveira, Renata Maria Colodette, Rosângela Minardi Mitre Cotta, Luciana Saraiva da Silva and Tiago Ricardo Moreira
    Citation: BMC Nephrology 2022 23:257
  35. To investigate the relationship between serum uric acid levels and glomerular ischemic lesions in patients with immunoglobulin A nephropathy (IgAN) and the relevant risk factors.

    Authors: Bolong Fang, Yamin Yu, Xiaowei Dong, Lin Qi, Yan Wang, Fang Dai, Lan Wei and Yajie Kang
    Citation: BMC Nephrology 2022 23:255
  36. Human Kidney Injury Molecule-1, also known as HAVCR-1 (Hepatitis A virus cellular receptor 1), belongs to the cell-surface protein of immunoglobulin superfamily involved in the phagocytosis by acting as scaven...

    Authors: F. Abid, Z. Rubab, S. Fatima, A. Qureshi, A. Azhar and A. Jafri
    Citation: BMC Nephrology 2022 23:254

    The Correction to this article has been published in BMC Nephrology 2022 23:286

  37. Alport syndrome is a hereditary kidney disease characterized by hematuria and proteinuria. Although there have been reports of autosomal dominant COL4A4 variants, this is likely an underdiagnosed condition. Impro...

    Authors: Jenelle Cocorpus, Megan M Hager, Corinne Benchimol, Vanesa Bijol, Fadi Salem, Sumit Punj, Laura Castellanos, Pamela Singer, Christine B Sethna and Abby Basalely
    Citation: BMC Nephrology 2022 23:253
  38. Hispanic Americans receive disproportionately fewer organ transplants than non-Hispanic whites. In 2018, the Hispanic Kidney Transplant Program (HKTP) was established as at the University of Colorado Hospital ...

    Authors: Madhura Pande, Monica Grafals, Katherine Rizzolo, Elizabeth Pomfret and Jessica Kendrick
    Citation: BMC Nephrology 2022 23:251
  39. Recently, early graft loss has become very rare in living-related kidney transplantation (LKT) as a result of decreased risk of hyperacute rejection and improvements in immunosuppressive regimens. Post-transpl...

    Authors: Qianqian Wu, Xiaohui Tian, Nianqiao Gong, Jin Zheng, Dandan Liang, Xue Li, Xia Lu, Wujun Xue, Puxun Tian and Jiqiu Wen
    Citation: BMC Nephrology 2022 23:249
  40. Distal renal tubular acidosis (dRTA) is the most common type of renal tubular acidosis (RTA) in children. Pediatric dRTA is usually genetic and rarely occurs due to acquired issues such as obstructive uropathi...

    Authors: Dara Ninggar Santoso, Fira Alyssa Gabriella Sinuraya and Cahyani Gita Ambarsari
    Citation: BMC Nephrology 2022 23:248
  41. The clinical and pathological impact factors for renal function recovery in acute kidney injury (AKI) on the progression of renal function in primary membranous nephropathy (PMN) with AKI patients have not yet...

    Authors: Tianxin Chen, Ying Zhou, Jianfen Zhu, Xinxin Chen and Jingye Pan
    Citation: BMC Nephrology 2022 23:247
  42. Over half of the patients with hepatitis B virus associated membranous nephropathy (HBV-MN) were found to be phospholipase A2 receptor (PLA2R) positive. Whether MN is really secondary to hepatitis B or just co...

    Authors: Ruiying Chen, Jia Wang, Qionghong Xie, Jianming Zheng, Shaojun Liu, Jun Xue and Chuanming Hao
    Citation: BMC Nephrology 2022 23:246

Affiliated with

Annual Journal Metrics

  • Citation Impact
    2.585 - 2-year Impact Factor (2021)
    3.049 - 5-year Impact Factor (2021)
    1.101 - SNIP (Source Normalized Impact per Paper)
    0.759 - SJR (SCImago Journal Rank)

    52 days to first decision for all manuscripts (Median)
    63 days to first decision for reviewed manuscripts only (Median)

    2,554,740 downloads (2021)
    2,507 Altmetric mentions (2021)

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal